HEALTH CATALYST INC's ticker is HCAT and the CUSIP is 42225T107. A total of 131 filers reported holding HEALTH CATALYST INC in Q2 2020. The put-call ratio across all filers is 0.33 and the average weighting 1.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $470,346 | -75.6% | 62,463 | -69.9% | 0.00% | -75.0% |
| Q4 2023 | $1,924,589 | +64.8% | 207,839 | +80.1% | 0.00% | +33.3% |
| Q3 2023 | $1,168,050 | -64.7% | 115,420 | -56.3% | 0.00% | -62.5% |
| Q2 2023 | $3,304,788 | -32.7% | 264,383 | -37.1% | 0.01% | -42.9% |
| Q1 2023 | $4,906,990 | +28.3% | 420,479 | +16.8% | 0.01% | +16.7% |
| Q4 2022 | $3,825,748 | +26.9% | 359,901 | +15.8% | 0.01% | +20.0% |
| Q3 2022 | $3,015,000 | -51.2% | 310,798 | -27.1% | 0.01% | -50.0% |
| Q2 2022 | $6,182,000 | +73.8% | 426,616 | +213.4% | 0.02% | +100.0% |
| Q1 2022 | $3,557,000 | -59.2% | 136,113 | -26.9% | 0.01% | -56.5% |
| Q1 2021 | $8,711,000 | +191.4% | 186,261 | +171.3% | 0.02% | +155.6% |
| Q4 2020 | $2,989,000 | +244.8% | 68,654 | +190.0% | 0.01% | +200.0% |
| Q3 2020 | $867,000 | +251.0% | 23,676 | +150.8% | 0.00% | +50.0% |
| Q1 2020 | $247,000 | – | 9,441 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Daventry Group, LP | 2,247,053 | $14,358,669 | 6.41% |
| First Light Asset Management, LLC | 3,956,089 | $25,279,409 | 2.22% |
| Nepsis Inc. | 1,253,080 | $8,007,181 | 2.16% |
| Granahan Investment Management | 1,042,733 | $6,663,064 | 0.27% |
| Invenomic Capital Management LP | 850,581 | $5,435,213 | 0.26% |
| PIER 88 INVESTMENT PARTNERS LLC | 130,240 | $832,234 | 0.19% |
| ClariVest Asset Management LLC | 285,627 | $1,825,156 | 0.19% |
| KENNEDY CAPITAL MANAGEMENT LLC | 1,274,844 | $8,146,253 | 0.17% |
| CVS HEALTH Corp | 32,273 | $206,221 | 0.10% |
| Olympiad Research LP | 18,987 | $121,327 | 0.09% |